EUVIMEDEUVIMED entdecken
Kommentar

Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research

Mishka Terplan, Anne D Lyerly, Hendree Jones

JAMA Internal Medicine · 01.05.2026 · 186 (5) · 544

DOI: 10.1001/jamainternmed.2026.0068 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.05.2026. Verfasst von Mishka Terplan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Friends Research Institute, Baltimore, Maryland. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Friends Research Institute, Baltimore, Maryland.
  • University of North Carolina, Chapel Hill.

Zitieren

APA

Terplan, M., Lyerly, A. D., & Jones, H. (2026). Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research. JAMA Internal Medicine, 186(5), 544. https://doi.org/10.1001/jamainternmed.2026.0068

Vancouver

Terplan M, Lyerly AD, Jones H. Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research. JAMA Internal Medicine. 2026;186(5):544. doi:10.1001/jamainternmed.2026.0068

BibTeX
@article{Terplan2026,
  author = {Terplan, Mishka and Lyerly, Anne D and Jones, Hendree},
  title = {Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {5},
  pages = {544},
  doi = {10.1001/jamainternmed.2026.0068}
}
Kostenlos starten →